Back to search

Peptide record

TPDB42696

MIP(R9A) Anticancer standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42696
MIP(R9A)
Anticancer
Cancer-related peptides
ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 Peptipedia SATPdb dbACP iACP-DRLF
standard
No
A 12-aa standard natural anticancer peptide sequence curated from ACP740 _ACP240, AntiCP 2.0, CancerPPD 2.0, and other sources, with an available 3D structural model.
Sequence
PRFWEYWLALME
Physicochemical Analysis
C81H109N17O18S1
NDCQGHIKSTV
ELW
1640.92
4.26
1
2
8
-1
-1.99
-0.175
73.33
Mammalian: >20 hour Yeast: >20 hour E.coli: ?
12490
761.16
1
Residue Composition
number
1
A
1
R
0
N
0
D
0
C
2
E
0
Q
0
G
0
H
0
I
2
L
0
K
1
M
1
F
1
P
0
S
0
T
2
W
1
Y
0
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 0 C: 0 E: 2 Q: 0 G: 0 H: 0 I: 0 L: 2 K: 0 M: 1 F: 1 P: 1 S: 0 T: 0 W: 2 Y: 1 V: 0
Chemical Descriptors
12
C81H109N17O18S1
1640.92
4.26
-1
-1.99
-0.175
Free
L
Linear
Free
Antitumor
E3 ubiquitin-protein ligase
Evidence Records 1 records
Evidence 1 Activity

Activity

IC50
IC50 =0.02 µM
Anticancer
0.02 µM

Target

Colon Cancer
HCT-116-p53+/+
Colon

Assay & Model

Immunoprecipitation assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2011

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.